Cargando…

Physical Activity as a New Tool to Evaluate the Response to Omalizumab and Mepolizumab in Severe Asthmatic Patients: A Pilot Study

Asthma is a chronic inflammatory airway disease, representing one of the most severe pathologies in developed countries. Based on a report of the World Health Organization (WHO), it affects about 300 million people worldwide. Few studies have analyzed the effects of daily life physical activity (PA)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carpagnano, Giovanna Elisiana, Sessa, Francesco, Scioscia, Giulia, Lacedonia, Donato, Foschino, Maria Pia, Venuti, Maria Pia, Triggiani, Antonio Ivano, Valenzano, Anna, Resta, Onofrio, Cibelli, Giuseppe, Messina, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6992710/ https://www.ncbi.nlm.nih.gov/pubmed/32038267 http://dx.doi.org/10.3389/fphar.2019.01630

Ejemplares similares

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2021)

Switching from omalizumab to mepolizumab: real-life experience from Southern Italy
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2020)

Omalizumab as add‐on therapy in a patient with severe asthma and OSA
por: Scioscia, Giulia, et al.
Publicado: (2020)

Severe uncontrolled asthma with bronchiectasis: a pilot study of an emerging phenotype that responds to mepolizumab
por: Carpagnano, Giovanna E, et al.
Publicado: (2019)

Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma–COPD overlap syndrome phenotype
por: Lacedonia, Donato, et al.
Publicado: (2017)

Early effectiveness of type-2 severe asthma treatment with dupilumab in a real-life setting; a FeNO-driven choice that leads to winning management
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2022)

Effectiveness of Benralizumab in Improving the Quality of Life of Severe Eosinophilic Asthmatic Patients: Our Real-Life Experience
por: Scioscia, Giulia, et al.
Publicado: (2021)

A survey of fungal microbiota in airways of healthy volunteer subjects from Puglia (Apulia), Italy
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2019)

MicroRNA expression profile during different conditions of hypoxia
por: Lacedonia, Donato, et al.
Publicado: (2018)

Impact of smoking, COPD and comorbidities on the mortality of COVID-19 patients
por: Lacedonia, Donato, et al.
Publicado: (2021)

Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region
por: Resta, Emanuela, et al.
Publicado: (2022)

The Role of Airways 17β-Estradiol as a Biomarker of Severity in Postmenopausal Asthma: A Pilot Study
por: Scioscia, Giulia, et al.
Publicado: (2020)

Transthoracic ultrasound sign in severe asthmatic patients: a lack of “gliding sign” mimic pneumothorax
por: Del Colle, Anna, et al.
Publicado: (2019)

Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2018)

Surgical Mask and N95 in Healthcare Workers of Covid-19 Departments: Clinical and Social Aspects
por: Gelardi, Matteo, et al.
Publicado: (2020)

Exhaled Breath Temperature Home Monitoring to Detect NSCLC Relapse: Results from a Pilot Study
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2022)

Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease
por: Dragonieri, Silvano, et al.
Publicado: (2016)

Microparticles in sputum of COPD patients: a potential biomarker of the disease?
por: Lacedonia, Donato, et al.
Publicado: (2016)

Tocilizumab and liver injury in patients with COVID-19
por: Serviddio, Gaetano, et al.
Publicado: (2020)

Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis
por: Portacci, Andrea, et al.
Publicado: (2023)

Real life experience of molnupiravir as a treatment of SARS-CoV-2 infection in vaccinated and unvaccinated patients: a letter on its effectiveness at preventing hospitalization
por: Scioscia, Giulia, et al.
Publicado: (2022)

Obstructive Sleep Apnea: A Look towards Micro-RNAs as Biomarkers of the Future
por: Moriondo, Giorgia, et al.
Publicado: (2022)

EVs-miRNA: The New Molecular Markers for Chronic Respiratory Diseases
por: Soccio, Piera, et al.
Publicado: (2022)

Benralizumab in Patients with Severe Eosinophilic Asthma: A Multicentre Real-Life Experience
por: Scioscia, Giulia, et al.
Publicado: (2023)

How Are We Handling the Post-COVID Patients? The Dance of Uncertainties
por: Lacedonia, Donato, et al.
Publicado: (2021)

Extracellular Vesicle Surface Signatures in IPF Patients: A Multiplex Bead-Based Flow Cytometry Approach
por: d’Alessandro, Miriana, et al.
Publicado: (2021)

Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy
por: Carpagnano, Giovanna E, et al.
Publicado: (2014)

Obstructive Sleep Apnea Worsens Progression-Free and Overall Survival in Human Metastatic Colorectal Carcinoma
por: Lacedonia, Donato, et al.
Publicado: (2021)

Effect of Hypoxia-Induced Micro-RNAs Expression on Oncogenesis
por: Moriondo, Giorgia, et al.
Publicado: (2022)

The Burden of Respiratory Alterations during Sleep on Comorbidities in Obstructive Sleep Apnoea (OSA)
por: Tondo, Pasquale, et al.
Publicado: (2022)

Clinical Evaluation and Management of Overlap Syndrome (OS) and Obesity Hypoventilation Syndrome (OHS)
por: Tondo, Pasquale, et al.
Publicado: (2022)

Searching for airways biomarkers useful to identify progressive pulmonary fibrosis
por: Soccio, Piera, et al.
Publicado: (2023)

New panel of microsatellite alterations detectable in the EBC for lung cancer prognosis
por: Carpagnano, Giovanna E, et al.
Publicado: (2016)

The Role of Transthoracic Ultrasound in the Study of Interstitial Lung Diseases: High-Resolution Computed Tomography Versus Ultrasound Patterns: Our Preliminary Experience
por: Lacedonia, Donato, et al.
Publicado: (2021)

Inhaled Medications in Chronic Respiratory Diseases: Analysis of Real-Life Use in Puglia (Apulia), Italy
por: Scioscia, Giulia, et al.
Publicado: (2023)

MiRNA and Exosomal miRNA as New Biomarkers Useful to Phenotyping Severe Asthma
por: Soccio, Piera, et al.
Publicado: (2023)

Transthoracic ultrasound shear wave elastography for the study of subpleural lung lesions
por: Quarato, Carla Maria Irene, et al.
Publicado: (2022)

Anaphylactic risk related to omalizumab, benralizumab, reslizumab, mepolizumab, and dupilumab
por: Li, Lisha, et al.
Publicado: (2021)

Criteria of prescription of antibiotics and systemic corticosteroids among pulmonologists and general practictioners during asthma and COPD exacerbations: a southern Italian survey
por: Dragonieri, Silvano, et al.
Publicado: (2021)

COVID-19 Pneumonia: The Great Ultrasonography Mimicker
por: Lacedonia, Donato, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6jc2nabjtl56kep8r8q7pt9rpp